Overview

A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
A phase 1 study of E2022 tape formulation in healthy elderly males to evaluate the safety and pharmacokinetics.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Donepezil